These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23548557)

  • 41. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.
    Jois P; Mebazaa A
    Semin Nephrol; 2012 Jan; 32(1):26-30. PubMed ID: 22365159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrafiltration for the management of acute decompensated heart failure.
    Wertman BM; Gura V; Schwarz ER
    J Card Fail; 2008 Nov; 14(9):754-9. PubMed ID: 18995180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute cardiorenal syndrome in acute heart failure: focus on renal replacement therapy.
    Schaubroeck HA; Gevaert S; Bagshaw SM; Kellum JA; Hoste EA
    Eur Heart J Acute Cardiovasc Care; 2020 Oct; 9(7):802-811. PubMed ID: 32597679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peritoneal dialysis allows successful cardiac transplantation in patients with refractory heart failure.
    Quirós-Ganga PL; Remón-Rodríguez C; Tejuca-Marenco M; de la Espada-Piña V
    Nefrologia; 2015; 35(1):121-4. PubMed ID: 25611845
    [No Abstract]   [Full Text] [Related]  

  • 45. Ultrafiltration therapy for cardiorenal syndrome: physiologic basis and contemporary options.
    Ross EA; Kazory A
    Blood Purif; 2012; 34(2):149-57. PubMed ID: 23095414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peritoneal dialysis in patients with heart failure.
    Van Der Sande FM; Cnossen TT; Cornelis T; Konings CJ; Kooman JP; Leunissen KM
    Minerva Urol Nefrol; 2012 Sep; 64(3):163-72. PubMed ID: 22971681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluid removal in acute heart failure: diuretics versus devices.
    Krishnamoorthy A; Felker GM
    Curr Opin Crit Care; 2014 Oct; 20(5):478-83. PubMed ID: 25111680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiorenal syndrome: pathophysiology and treatment.
    Shchekochikhin D; Schrier RW; Lindenfeld J
    Curr Cardiol Rep; 2013 Jul; 15(7):380. PubMed ID: 23700289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrafiltration versus diuretics in congestive heart failure.
    Flessner MF; Zsom L; Juncos L
    Am J Med Sci; 2010 Jul; 340(1):38-41. PubMed ID: 20610971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The peritoneal ultrafiltration in patients with cardio-renal disease].
    Corciulo R; Corciulo S
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):86-103. PubMed ID: 28682031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute cardiac insufficiency. Do we finally have an opportunity to improve the prognosis?].
    Formiga F; Manzano Espinoza L
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():1-2. PubMed ID: 24930075
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of extracorporeal ultrafiltration in patients with diuretic-resistant heart failure.
    Nakazawa N; Nakabayashi K; Oka T
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27702934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome.
    Shah RV; Givertz MM
    Curr Heart Fail Rep; 2009 Sep; 6(3):176-81. PubMed ID: 19723459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrafiltration in the management of acute decompensated heart failure.
    Mielniczuk LM; Haddad H; Davies RA
    Curr Opin Cardiol; 2010 Mar; 25(2):155-60. PubMed ID: 19996964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Costanzo MR; Negoianu D; Fonarow GC; Jaski BE; Bart BA; Heywood JT; Nabut JL; Schollmeyer MP
    Am Heart J; 2015 Sep; 170(3):471-82. PubMed ID: 26385030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrafiltration in the management of heart failure.
    Costanzo MR
    Curr Opin Crit Care; 2008 Oct; 14(5):524-30. PubMed ID: 18787444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience.
    Teo LY; Lim CP; Neo CL; Teo LW; Ng SL; Chan LL; Kaushik M; Sim KL
    Singapore Med J; 2016 Jul; 57(7):378-83. PubMed ID: 26778634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "AVOID"ing harm by a double-edged sword: is there a role for ultrafiltration in heart failure?
    Kazory A
    Kidney Int; 2016 Mar; 89(3):527-8. PubMed ID: 26880445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis.
    Broekman KE; Sinkeler SJ; Waanders F; Bartels GL; Navis G; Janssen WM
    Heart Fail Rev; 2014 Nov; 19(6):709-16. PubMed ID: 24442648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of intermittent ultrafiltration in decompensated, diuretic-resistant heart failure--six case reports].
    Snopek G; Kotlarska J; Daniewska D; Zelek T; Drewniak W; Król-Jaskulska A; Dabrowski M
    Kardiol Pol; 2008 Nov; 66(11):1202-4. PubMed ID: 19105097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.